Amulet vs LAmbre: Left Atrial Appendage Closure in NVAF patients at high bleeding risk
Official title: Comparison of the Amplatzer Amulet Versus LAmbre Device for Left Atrial Appendage Closure: the CALAMBRE Randomized Clinical Trial
Run by Fundación EPIC · NCT07260474 · Data updated 2026-11-12
This study tests whether the Amplatzer Amulet or the LAmbre device works better for closing the left atrial appendage in adults with non-valvular atrial fibrillation who are at high risk of stroke and bleeding.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Fundación EPIC Academic / other |
| Locations | 1 site (Fuencarral-El Pardo) |
| Status | Recruiting |
| Started | May 5, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | January 31, 2027 |
| Registry record updated | October 7, 2026 |
| Trial ID | NCT07260474 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with non-valvular atrial fibrillation, CHA2DS2-VASc ≥2, and at least one Munich-consensus high-bleeding-risk criterion, suitable for either device after preprocedural imaging.
✕Probably not a fit
Patients who do not meet inclusion criteria, have contraindications to the devices, or have factors leading to high risk of adverse events may derive no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this multicenter, prospective, randomized trial, adults with non-valvular atrial fibrillation at high embolic and bleeding risk are assigned to left atrial appendage closure using either the Amplatzer Amulet or the LAmbre device. The trial compares implantation success, the degree of appendage closure, and clinical outcomes during follow-up. All participants undergo preprocedural imaging to confirm suitability for closure and absence of LAA thrombus. CE-marked devices are used under controlled, ethical conditions with informed consent and standard safety monitoring.
Why it matters
Potential benefit: If successful, the study could clarify which device provides safer and more reliable closure, potentially reducing stroke risk for high-risk patients.
How similar studies have gone: Earlier experiences with left atrial appendage closure devices have shown benefits in selected populations, but direct, randomized comparisons like this are less common.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: (MUST MEET ALL INCLUSION CRITERIA) * Patient with aged ≥18 years AND; * Patient have non-valvular atrial (NVAF) with a CHA2DS2-VASc score ≥2, and presented at least one high-bleeding-risk criterion according to the Munich consensus document AND; * Patient are required to undergo preprocedural TEE / CCTA to confirm the absence of LAA thrombus and to ensure that LAA anatomy is suitable for closure with either device. * Patient who has been informed of the characteristics of the study and has provided written informed consent.. Exclusion Criteria: (MUST NOT MEET ANY EXCLUSION CRITERIA) * Patient life expectancy \<1 year (terminal illness). * Patient with requirement for oral anticoagulation therapy for any indication other than non-valvular atrial fibrillation. * Patient with prior surgical ligation or obliteration of the left atrial appendage. * Patient with history of allergic reaction or intolerance to any material used in the study devices or to any of the antithrombotic agents required post-procedure. * Patient with active systemic infection. * Patient with concurrent participation in another investigational study that may affect study results. * Patient with inability or unwillingness to comply with the study protocol or follow-up requirements. * Patient pregnant or breastfeeding women.
Where it's running
-
Hospital Universitario La Paz
Fuencarral-El Pardo, Spain Recruiting
Study contacts
- Study coordinator: BORJA Rivero-Santana, MD, PhD
- Email: borja.riversa@gmail.com
- Phone: 0034696170677
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.